The Adherens Junction Protein Afadin Is an AKT Substrate that Regulates Breast Cancer Cell Migration

被引:40
作者
Elloul, Sivan [1 ]
Kedrin, Dmitriy [1 ]
Knoblauch, Nicholas W. [1 ]
Beck, Andrew H. [1 ]
Toker, Alex [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
关键词
MAMMARY EPITHELIAL-CELLS; PHOSPHOINOSITIDE 3-KINASE PATHWAY; ADHESION MOLECULE; NIH3T3; CELLS; TUMOR-GROWTH; ACTIVATION; INHIBITOR; AKT/PKB; KINASE; PHOSPHORYLATION;
D O I
10.1158/1541-7786.MCR-13-0398
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The PI3K-AKT signaling pathway regulates all phenotypes that contribute to progression of human cancers, including breast cancer. AKT mediates signal relay by phosphorylating numerous substrates, which are causally implicated in biologic responses such as cell growth, survival, metabolic reprogramming, migration, and invasion. Here a new AKT substrate is identified, the adherens junction protein Afadin, which is phosphorylated by AKT at Ser1718. Importantly, under conditions of physiologic IGF-1 signaling and oncogenic PI3K and AKT, Afadin is phosphorylated by all AKT isoforms, and this phosphorylation elicits a relocalization of Afadin from adherens junctions to the nucleus. Also, phosphorylation of Afadin increased breast cancer cell migration that was dependent on Ser1718 phosphorylation. Finally, nuclear localization of Afadin was observed in clinical breast cancer specimens, indicating that regulation of Afadin by the PI3K-AKT pathway has pathophysiologic significance. (C)2013 AACR.
引用
收藏
页码:464 / 476
页数:13
相关论文
共 47 条
[1]   The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation [J].
Alao, John P. ;
Sunnerhagen, Per .
RADIATION ONCOLOGY, 2009, 4 :51
[2]   A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J].
BROWN, EJ ;
ALBERS, MW ;
SHIN, TB ;
ICHIKAWA, K ;
KEITH, CT ;
LANE, WS ;
SCHREIBER, SL .
NATURE, 1994, 369 (6483) :756-758
[3]   AF6/s-Afadin is a dual residency protein and localizes to a novel subnuclear compartment [J].
Buchert, Michael ;
Poon, Carole ;
King, James A. J. ;
Baechi, Thomas ;
D'Abaco, Giovanna ;
Hollande, Frederic ;
Hovens, Christopher M. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 210 (01) :212-223
[4]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[5]   The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration [J].
Chin, Y. Rebecca ;
Toker, Alex .
MOLECULAR CELL, 2010, 38 (03) :333-344
[6]   Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer [J].
Chin, Y. Rebecca ;
Toker, Alex .
CELLULAR SIGNALLING, 2009, 21 (04) :470-476
[7]   Distinct Biological Roles for the Akt Family in Mammary Tumor Progression [J].
Dillon, Rachelle L. ;
Muller, William J. .
CANCER RESEARCH, 2010, 70 (11) :4260-4264
[8]   Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling [J].
Ding, VW ;
Chen, RH ;
McCormick, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32475-32481
[9]   Akt/PKB regulates actin organization and cell motility via girdin/APE [J].
Enomoto, A ;
Murakami, H ;
Asai, N ;
Morone, N ;
Watanabe, T ;
Kawai, K ;
Murakumo, Y ;
Usukura, J ;
Kaibuchi, K ;
Takahashi, M .
DEVELOPMENTAL CELL, 2005, 9 (03) :389-402
[10]   Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth [J].
Fournier, G. ;
Cabaud, O. ;
Josselin, E. ;
Chaix, A. ;
Adelaide, J. ;
Isnardon, D. ;
Restouin, A. ;
Castellano, R. ;
Dubreuil, P. ;
Chaffanet, M. ;
Birnbaum, D. ;
Lopez, M. .
ONCOGENE, 2011, 30 (36) :3862-3874